NSTG NanoString Technologies, Inc. Stock Quote

NSTG [NASD]

Index	-	P/E	-	EPS (ttm)	-2.31	Insider Own	0.60%	Shs Outstand	45.27M	Perf Week	-3.27%
Market Cap	2.60B	Forward P/E	-	EPS next Y	-2.19	Insider Trans	-55.17%	Shs Float	44.66M	Perf Month	13.38%
Income	-99.10M	PEG	-	EPS next Q	-0.54	Inst Own	-	Short Float	8.57%	Perf Quarter	-10.13%
Sales	133.60M	P/S	19.46	EPS this Y	-139.40%	Inst Trans	0.04%	Short Ratio	11.26	Perf Half Y	-16.62%
Book/sh	4.85	P/B	11.89	EPS next Y	2.70%	ROA	-20.70%	Target Price	77.20	Perf Year	29.82%
Cash/sh	8.83	P/C	6.53	EPS next 5Y	-	ROE	-45.80%	52W Range	34.31 - 86.42	Perf YTD	-13.74%
Dividend	-	P/FCF	-	EPS past 5Y	-3.30%	ROI	-19.90%	52W High	-33.24%	Beta	1.72
Dividend %	-	Quick Ratio	10.10	Sales past 5Y	13.40%	Gross Margin	53.70%	52W Low	68.14%	ATR	2.77
Employees	579	Current Ratio	10.80	Sales Q/Q	50.00%	Oper. Margin	-66.00%	RSI (14)	50.25	Volatility	5.85% 4.42%
Optionable	Yes	Debt/Eq	1.02	EPS Q/Q	16.90%	Profit Margin	-74.10%	Rel Volume	2.32	Prev Close	54.50
Shortable	Yes	LT Debt/Eq	1.02	Earnings	Aug 04 AMC	Payout	-	Avg Volume	340.01K	Price	57.69
Recom	1.80	SMA20	0.92%	SMA50	-1.18%	SMA200	-10.60%	Volume	789,280	Change	5.85%

Jan-06-21

Upgrade

Cowen

Market Perform → Outperform

$75

Sep-09-20

Initiated

Morgan Stanley

Equal-Weight

$43

Nov-15-19

Initiated

Stifel

Buy

Oct-09-18

Initiated

UBS

Buy

Oct-12-17

Downgrade

Janney

Buy → Neutral

Apr-20-17

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Dec-11-13

Upgrade

Robert W. Baird

Neutral → Outperform

$12 → $18

Sep-09-21 04:00PM	NanoString to Webcast Presentation from the Baird 2021 Global Healthcare Conference Business Wire
Sep-01-21 04:00PM	NanoString to Webcast Presentation from the 19th Annual Morgan Stanley Global Healthcare Conference Business Wire +5.05%
Aug-31-21 09:02AM	Is NanoString Technologies (NASDAQ:NSTG) A Risky Investment? Simply Wall St.
06:00AM	NanoStrings GeoMx Digital Spatial Profiling Platform Reveals Insights Into the Immune Landscape of Cancer in Publication in the Journal Cell Business Wire
Aug-04-21 05:45PM	NanoString Technologies (NSTG) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM	NanoString Releases Operating Results for Second Quarter of 2021 Business Wire
Jul-28-21 03:03PM	NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-13-21 01:16PM	Hedge Funds Arent Crazy About NanoString Technologies Inc (NSTG) Anymore Insider Monkey
Jul-08-21 06:00AM	NanoString to Release Second Quarter 2021 Operating Results and Host Conference Call on Wednesday, August 4, 2021 Business Wire
Jun-22-21 06:00AM	NanoString Launches nCounter Stem Cell Characterization Panel to Advance the Development of Stem Cell Therapy Business Wire
Jun-15-21 06:00AM	NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer Business Wire
Jun-02-21 05:39AM	Shareholders Are Thrilled That The NanoString Technologies (NASDAQ:NSTG) Share Price Increased 283% Simply Wall St.
May-27-21 06:00AM	NanoString to Webcast Presentation from the Jefferies Virtual Healthcare Conference Business Wire
May-20-21 06:00AM	NanoString to Webcast Presentation from the UBS Global Healthcare Conference Business Wire
May-17-21 06:00AM	NanoString's GeoMx Mouse Whole Transcriptome Atlas Expands Leadership in Spatial Genomics by Enabling Genome-Wide RNA Profiling Business Wire
May-10-21 05:15PM	NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates Zacks -11.67%
04:00PM	NanoString Technologies Releases Operating Results for First Quarter of 2021 Business Wire
May-04-21 03:00AM	NanoStrings Digital Spatial Profiling Platform Used to Create Foundational Dataset Revealing Insights into COVID-19 Business Wire -5.40%
Apr-20-21 09:22AM	Is NSTG Stock A Buy or Sell? Insider Monkey
Apr-08-21 06:00AM	NanoString Highlights Spatial Biology Research from the 2021 American Association of Cancer Research (AACR) Conference Business Wire
Apr-06-21 06:00AM	NanoString to Release First Quarter 2021 Operating Results and Host Conference Call on Monday, May 10, 2021 Business Wire +5.62%
Mar-31-21 06:00AM	NanoString's GeoMx Digital Spatial Profiler Reveals Insights into COVID-19 in Two New Nature Publications Business Wire +8.74%
Mar-22-21 10:13AM	NanoString, Illumina Accelerator and Doloromics Announce GeoMx Digital Spatial Profiling Collaboration to Develop Novel Pain Therapeutics Business Wire
Mar-09-21 06:00AM	NanoString Appoints Dr. Dana Rollison and Janet George to Board of Directors Business Wire +5.14%
Mar-04-21 02:16AM	Is NanoString Technologies (NASDAQ:NSTG) Weighed On By Its Debt Load? Simply Wall St. -11.43%
Mar-01-21 05:25PM	NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates Zacks +6.55%
04:56PM	Recap: NanoString Technologies Q4 Earnings Benzinga
04:01PM	NanoString Technologies Releases Fourth Quarter and Full Year 2020 Operating Results and Provides 2021 Financial Outlook Business Wire
10:06AM	NanoString Launches Technology Access Program for the Spatial Molecular Imager (SMI) Platform and Showcases Spatially Resolved Transcriptomic Research at 2021 Advances in Genome Biology and Technology (AGBT) Conference Business Wire
Feb-24-21 06:00AM	NanoString to Webcast Presentation from the 41st Annual Cowen Healthcare Conference Business Wire
Feb-22-21 06:00AM	NanoString Announces the Launch of the Whole Transcriptome Atlas with Data to be Presented at the Third Annual Spatial Genomics Summit on February 23, 2021 Business Wire -6.18%
Feb-17-21 06:00AM	NanoString to Webcast Presentation from the 10th Annual SVB Leerink Global Healthcare Conference Business Wire
Feb-11-21 06:00AM	NanoString to Release Fourth Quarter and Fiscal Year 2020 Operating Results and Host Conference Call on Monday, March 1, 2021 Business Wire
Feb-09-21 06:00AM	Nature Medicine Publishes First Study Utilizing NanoStrings GeoMx Digital Spatial Profiler Whole Transcriptome Atlas Business Wire
Jan-10-21 03:00PM	NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020 Business Wire
Jan-06-21 12:14PM	Nature Methods Selects Spatially-Resolved Transcriptomics as the Method of the Year for 2020 Business Wire
Jan-04-21 04:01PM	NanoString to Present at the 39th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-18-20 08:51AM	Is NSTG A Good Stock To Buy Now? Insider Monkey
Dec-09-20 06:00AM	NanoStrings GeoMx Digital Spatial Profiler Identifies Diverse Immune Responses Within COVID-19 Patients in Study Published in Nature Communications Business Wire
Dec-01-20 06:00AM	NanoString Unveils Spatial Molecular Imaging Platform, Complementing GeoMx DSP to Provide Compelling Product Roadmap for Spatial Biology Business Wire +10.05%
Nov-18-20 04:01PM	NanoString to Host Virtual Investor and Analyst Day on December 1st, 2020 Business Wire
Nov-17-20 06:00AM	NanoString and Oregon Health & Science University Announce Collaboration to Develop GeoMx-Based Spatial Profiling Assays for Breast Cancer Business Wire +5.02%
Nov-12-20 04:01PM	NanoString to Present at the Stifel 2020 Virtual Healthcare Conference Business Wire +5.13%
06:47AM	Here's What Analysts Are Forecasting For NanoString Technologies, Inc. (NASDAQ:NSTG) After Its Third-Quarter Results Simply Wall St.
Nov-11-20 06:00AM	NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC) Business Wire +12.81%
Nov-09-20 05:25PM	NanoString Technologies (NSTG) Reports Q3 Loss, Tops Revenue Estimates Zacks
05:21PM	NanoString Technologies: Q3 Earnings Insights Benzinga
04:01PM	NanoString Technologies Releases Operating Results for Third Quarter of 2020 Business Wire
06:00AM	NanoString Launches GeoMx DSP Protein Assays for Next Generation Sequencing Business Wire
Nov-06-20 04:01PM	NanoString to Present at the 29th Annual Credit Suisse Healthcare Conference Business Wire
Nov-02-20 12:31PM	Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-13-20 04:01PM	NanoString Technologies Announces Closing of Public Offering of $230.0 Million of Common Stock Including Exercise in Full of Option to Purchase Additional Shares Business Wire
Oct-08-20 09:33AM	OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users Business Wire -5.20%
Oct-07-20 07:58PM	NanoString Technologies Announces Pricing of Upsized Public Offering of $200 Million of Common Stock Business Wire
Oct-06-20 04:18PM	NanoString Technologies Announces Commencement of Public Offering of Common Stock Business Wire
04:06PM	NanoString Technologies Provides Preliminary Financial and Operational Highlights for Third Quarter 2020 Business Wire
Oct-05-20 06:00AM	NanoString to Release Third Quarter 2020 Operating Results and Host Conference Call on Monday, November 9, 2020 Business Wire
Sep-14-20 06:00AM	NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites Business Wire +6.51%
Sep-09-20 04:01PM	NanoString to Present at the 18th Annual Morgan Stanley Global Healthcare Conference Business Wire
09:44AM	Benzinga's Top Upgrades, Downgrades For September 9, 2020 Benzinga
06:00AM	NanoString Announces New GeoMx COVID-19 Consortium, Part of the GeoMx Translational Leadership Network Business Wire
Sep-03-20 04:01PM	NanoString to Present at the 2020 Baird Global Healthcare Conference Business Wire -7.56%
Aug-11-20 11:00AM	Is NanoString Technologies (NASDAQ:NSTG) A Risky Investment? Simply Wall St.
10:54AM	Did You Miss NanoString Technologies' (NASDAQ:NSTG) Impressive 151% Share Price Gain? Simply Wall St.
Aug-10-20 06:15PM	NanoString Technologies (NSTG) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM	NanoString Technologies Releases Operating Results for Second Quarter of 2020 Business Wire
Aug-07-20 08:46AM	Medical Products Stock Earnings on Aug 10: CGC, SDGR & More Zacks
Aug-06-20 06:00AM	NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler Business Wire
06:00AM	Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler PR Newswire
Aug-05-20 05:49PM	Were Hedge Funds Right About Buying NanoString Technologies Inc (NSTG)? Insider Monkey
Aug-03-20 12:31PM	Will NanoString Technologies (NSTG) Report Negative Earnings Next Week? What You Should Know Zacks
06:00AM	NanoString Extends Leadership in Spatial Genomics with Launch of GeoMx DSP Read-Out for Next Generation Sequencers Business Wire
Jul-08-20 06:00AM	NanoString to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020 Business Wire
Jul-02-20 08:39AM	NanoString Technologies (NSTG) Surges: Stock Moves 10.3% Higher Zacks +8.25%
Jun-23-20 11:06AM	Hedge Funds Getting Crazy About NanoString Technologies Inc (NSTG) Insider Monkey
Jun-17-20 05:05PM	Edited Transcript of NSTG.OQ earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-16-20 05:41PM	NanoString Announces New Products to Advance COVID-19 Disease Research Business Wire
May-20-20 09:00AM	NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data Business Wire
May-19-20 09:37AM	21 Risky Stocks That Might Have Borrowed More Than Is Good For Them Barrons.com
May-14-20 04:00PM	NanoString to Present at the UBS Global Healthcare Conference Business Wire +5.23%
May-12-20 06:00AM	Recent Publications Demonstrate the Performance of the GeoMx DSP and Establish New Standards for Spatial Profiling in Discovery & Translational Research Business Wire -7.95%
May-11-20 06:00AM	NanoString to Present at the Bank of America Health Care Conference Business Wire +7.12%
May-09-20 12:01PM	Nanostring Technologies (NSTG) Q1 2020 Earnings Call Transcript Motley Fool
May-07-20 06:35PM	NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:01PM	NanoString Technologies Releases Operating Results for First Quarter of 2020 Business Wire
Apr-15-20 09:00AM	Singapore Researchers Use NanoStrings nCounter Platform to Rapidly Profile the Response of the Immune System to the SARS-CoV-2 Virus Business Wire
Apr-07-20 06:34AM	Downgrade: Here's How Analysts See NanoString Technologies, Inc. (NASDAQ:NSTG) Performing In The Near Term Simply Wall St.
Apr-06-20 04:01PM	NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020 Business Wire +6.87%
Mar-27-20 09:47AM	Why NanoString Technologies (NSTG) Stock Might be a Great Pick Zacks -11.44%
Mar-07-20 07:05AM	Edited Transcript of NSTG earnings conference call or presentation 26-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Mar-05-20 06:00AM	NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes Business Wire
Mar-04-20 07:21AM	NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes Business Wire
Mar-03-20 09:41AM	Top Ranked Momentum Stocks to Buy for March 3rd Zacks
Mar-02-20 06:05AM	Will NanoString Technologies Continue to Surge Higher? Zacks
Feb-28-20 09:44AM	NanoString Technologies, Inc. Analysts Are Pretty Bullish On The Stock After Recent Results Simply Wall St.
Feb-26-20 04:00PM	NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook Business Wire
Feb-20-20 06:00AM	NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference Business Wire
Feb-19-20 12:31PM	NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Feb-18-20 06:00AM	NanoString to Present at the 40th Annual Cowen Healthcare Conference Business Wire
Feb-10-20 09:00AM	NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020 Business Wire

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq technologies. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Malloy Kirk	Director	Sep 13	Option Exercise	19.33	3,000	57,990	9,510	Sep 15 04:35 PM
Malloy Kirk	Director	Sep 13	Sale	59.37	3,000	178,110	6,510	Sep 15 04:35 PM
GRAY R BRADLEY	President and CEO	Sep 08	Option Exercise	6.72	12,500	84,000	169,158	Sep 10 04:38 PM
GRAY R BRADLEY	President and CEO	Sep 08	Sale	57.92	33,334	1,930,804	135,824	Sep 10 04:38 PM
BEECHEM JOSEPH M	SVP, Research & Development	Sep 02	Sale	61.14	23,114	1,413,206	68,270	Sep 03 05:13 PM
Bailey K Thomas	Chief Financial Officer	Aug 17	Option Exercise	11.85	7,845	92,963	7,845	Aug 19 04:18 PM
Bailey K Thomas	Chief Financial Officer	Aug 17	Sale	51.98	7,845	407,776	0	Aug 19 04:18 PM
Malloy Kirk	Director	Aug 16	Option Exercise	26.45	1,500	39,675	8,010	Aug 18 05:09 PM
Malloy Kirk	Director	Aug 16	Sale	55.82	1,500	83,730	6,510	Aug 18 05:09 PM
BROWN J. CHAD	SVP, Sales & Marketing	Jul 30	Option Exercise	17.82	11,106	197,920	11,106	Aug 03 04:49 PM
BROWN J. CHAD	SVP, Sales & Marketing	Jul 30	Sale	62.09	11,106	689,598	0	Aug 03 04:49 PM
Malloy Kirk	Director	Jul 13	Option Exercise	23.34	1,500	35,010	8,010	Jul 15 04:38 PM
Malloy Kirk	Director	Jul 13	Sale	61.16	1,500	91,740	6,510	Jul 15 04:38 PM
FINNEY ELISHA W	Director	Jun 16	Sale	58.70	2,760	162,012	4,650	Jun 17 07:04 PM
Malloy Kirk	Director	Jun 14	Option Exercise	7.47	168	1,255	1,158	Jun 15 04:34 PM
Malloy Kirk	Director	Jun 14	Sale	60.05	168	10,088	990	Jun 15 04:34 PM
BEECHEM JOSEPH M	SVP, Research & Development	Jun 11	Option Exercise	6.74	142,967	963,592	223,002	Jun 15 04:35 PM
BEECHEM JOSEPH M	SVP, Research & Development	Jun 11	Sale	58.94	131,827	7,770,339	91,175	Jun 15 04:35 PM
Bailey K Thomas	Chief Financial Officer	May 18	Option Exercise	11.85	5,229	61,962	5,229	May 20 04:24 PM
Bailey K Thomas	Chief Financial Officer	May 18	Sale	51.10	5,229	267,217	0	May 20 04:24 PM
GRAY R BRADLEY	President and CEO	May 12	Option Exercise	6.72	19,940	133,997	189,743	May 14 04:34 PM
GRAY R BRADLEY	President and CEO	May 12	Sale	52.94	33,333	1,764,570	156,410	May 14 04:34 PM
Malloy Kirk	Director	May 10	Option Exercise	16.36	1,500	24,540	2,490	May 12 04:24 PM
Malloy Kirk	Director	May 10	Sale	63.65	1,500	95,475	990	May 12 04:24 PM
HERSHBERG ROBERT	Director	Apr 15	Option Exercise	14.71	144	2,118	2,034	Apr 19 04:17 PM
HERSHBERG ROBERT	Director	Apr 15	Sale	73.91	144	10,642	1,890	Apr 19 04:17 PM
BROWN J. CHAD	SVP, Sales & Marketing	Mar 25	Sale	68.78	4,948	340,323	0	Apr 13 07:51 PM
GRAY R BRADLEY	President and CEO	Mar 18	Sale	65.96	21,684	1,430,277	169,803	Apr 13 07:54 PM
BEECHEM JOSEPH M	SVP, Research & Development	Mar 18	Sale	65.96	8,874	585,329	80,035	Apr 13 07:47 PM
Bailey K Thomas	Chief Financial Officer	Mar 17	Option Exercise	11.85	10,458	123,910	28,613	Mar 19 05:14 PM
Bailey K Thomas	Chief Financial Officer	Mar 17	Sale	65.63	28,613	1,877,898	0	Mar 19 05:14 PM
BROWN J. CHAD	SVP, Sales & Marketing	Mar 17	Sale	64.20	4,754	305,207	0	Mar 19 05:14 PM
BEECHEM JOSEPH M	SVP, Research & Development	Mar 16	Sale	66.32	1,161	76,998	88,909	Apr 13 07:47 PM
Bailey K Thomas	Chief Financial Officer	Mar 16	Sale	66.32	1,161	76,998	18,155	Apr 13 07:45 PM
GRAY R BRADLEY	President and CEO	Mar 16	Sale	66.32	5,179	343,471	191,487	Apr 13 07:54 PM
BEECHEM JOSEPH M	SVP, Research & Development	Mar 15	Option Exercise	0.00	5,376	0	81,554	Mar 17 08:15 PM
Bailey K Thomas	Chief Financial Officer	Mar 15	Option Exercise	0.00	5,376	0	19,375	Mar 17 08:15 PM
GRAY R BRADLEY	President and CEO	Mar 15	Option Exercise	0.00	21,994	0	177,305	Mar 17 08:14 PM
BROWN J. CHAD	SVP, Sales & Marketing	Mar 15	Option Exercise	0.00	5,376	0	5,453	Mar 17 08:14 PM
HERSHBERG ROBERT	Director	Mar 15	Option Exercise	11.20	1,500	16,800	3,390	Mar 17 04:25 PM
HERSHBERG ROBERT	Director	Mar 15	Sale	66.94	1,500	100,407	1,890	Mar 17 04:25 PM
BROWN J. CHAD	SVP, Sales & Marketing	Mar 12	Sale	64.66	9,050	585,173	77	Mar 15 04:40 PM
WAITE CHARLES P JR	Director	Mar 10	Option Exercise	7.47	10,168	75,955	12,058	Mar 12 04:32 PM
GRAY R BRADLEY	President and CEO	Mar 10	Option Exercise	5.06	25,000	126,571	155,702	Mar 12 04:33 PM
GRAY R BRADLEY	President and CEO	Mar 10	Sale	62.04	33,333	2,068,062	122,369	Mar 12 04:33 PM
WAITE CHARLES P JR	Director	Mar 10	Sale	62.50	10,168	635,500	1,890	Mar 12 04:32 PM
Malloy Kirk	Director	Mar 08	Option Exercise	12.80	2,500	32,010	3,490	Mar 10 04:19 PM
Malloy Kirk	Director	Mar 08	Sale	63.14	2,500	157,850	990	Mar 10 04:19 PM
BEECHEM JOSEPH M	SVP, Research & Development	Mar 05	Option Exercise	0.00	3,741	0	67,698	Mar 09 08:54 PM
BROWN J. CHAD	SVP, Sales & Marketing	Mar 05	Option Exercise	0.00	3,741	0	4,181	Mar 09 08:53 PM
GRAY R BRADLEY	President and CEO	Mar 05	Option Exercise	0.00	16,463	0	137,092	Mar 09 08:53 PM
Bailey K Thomas	Chief Financial Officer	Mar 05	Option Exercise	0.00	4,988	0	15,275	Mar 09 08:54 PM
HERSHBERG ROBERT	Director	Feb 16	Option Exercise	11.20	1,188	13,306	3,078	Feb 18 04:23 PM
BROWN J. CHAD	SVP, Sales & Marketing	Feb 16	Option Exercise	17.52	6,281	110,049	6,721	Feb 18 04:23 PM
BROWN J. CHAD	SVP, Sales & Marketing	Feb 16	Sale	84.65	6,281	531,687	440	Feb 18 04:23 PM
HERSHBERG ROBERT	Director	Feb 16	Sale	80.37	1,188	95,479	1,890	Feb 18 04:23 PM
BROWN J. CHAD	SVP, Sales & Marketing	Jan 28	Sale	63.18	8,229	519,908	440	Jan 29 04:17 PM
GRAY R BRADLEY	President and CEO	Jan 20	Sale	72.34	25,000	1,808,580	86,686	Jan 22 04:25 PM
HERSHBERG ROBERT	Director	Jan 15	Option Exercise	11.20	1,500	16,800	3,390	Jan 19 04:15 PM
HERSHBERG ROBERT	Director	Jan 15	Sale	72.62	1,500	108,923	1,890	Jan 19 04:15 PM
Malloy Kirk	Director	Jan 11	Option Exercise	12.80	2,500	32,010	3,490	Jan 13 04:36 PM
Malloy Kirk	Director	Jan 11	Sale	66.53	2,500	166,325	990	Jan 13 04:36 PM
HERSHBERG ROBERT	Director	Dec 15	Option Exercise	11.20	1,500	16,800	3,390	Dec 16 04:17 PM
HERSHBERG ROBERT	Director	Dec 15	Sale	69.33	1,500	103,994	1,890	Dec 16 04:17 PM
Norden Gregory	Director	Dec 07	Option Exercise	1.92	10,406	19,980	12,296	Dec 09 04:41 PM
WAITE CHARLES P JR	Director	Dec 07	Option Exercise	18.88	37,860	714,711	39,750	Dec 09 04:40 PM
WAITE CHARLES P JR	Director	Dec 07	Sale	60.47	37,860	2,289,380	1,890	Dec 09 04:40 PM
Norden Gregory	Director	Dec 07	Sale	58.32	10,406	606,892	1,890	Dec 09 04:41 PM
Bailey K Thomas	Chief Financial Officer	Nov 19	Option Exercise	23.34	12,709	296,628	12,709	Nov 20 04:56 PM
Bailey K Thomas	Chief Financial Officer	Nov 19	Sale	47.35	12,709	601,729	0	Nov 20 04:56 PM
Bailey K Thomas	Chief Financial Officer	Nov 18	Option Exercise	8.16	5,937	48,446	5,937	Nov 20 04:56 PM
Bailey K Thomas	Chief Financial Officer	Nov 18	Sale	48.21	5,937	286,197	0	Nov 20 04:56 PM
HERSHBERG ROBERT	Director	Nov 16	Option Exercise	11.20	1,500	16,800	3,390	Nov 18 04:17 PM
BROWN J. CHAD	SVP, Sales & Marketing	Nov 16	Option Exercise	17.52	6,281	110,049	6,721	Nov 18 04:18 PM
BROWN J. CHAD	SVP, Sales & Marketing	Nov 16	Sale	46.21	6,281	290,245	440	Nov 18 04:18 PM
HERSHBERG ROBERT	Director	Nov 16	Sale	46.67	1,500	70,002	1,890	Nov 18 04:17 PM
Malloy Kirk	Director	Nov 09	Option Exercise	12.80	2,500	32,010	3,490	Nov 12 05:00 PM
Malloy Kirk	Director	Nov 09	Sale	40.96	2,500	102,400	990	Nov 12 05:00 PM
HERSHBERG ROBERT	Director	Oct 15	Option Exercise	11.20	1,500	16,800	3,390	Oct 16 04:44 PM
HERSHBERG ROBERT	Director	Oct 15	Sale	39.35	1,500	59,019	1,890	Oct 16 04:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience